On March 17, 2026, Mainz Biomed N.V., operating as Quantum Cyber, announced a strategic update in response to the Trump Administration's National Cybersecurity Strategy. This strategy outlines the company's positioning within the rapidly evolving quantum and cyber defense landscape. The announcement includes the pre-funding of the second tranche of a private placement by significant shareholder David Lazar, totaling $6 million. The company is actively evaluating acquisition opportunities in quantum computing and cybersecurity sectors, aligning its strategy with federal priorities. The management believes that the convergence of quantum computing and cybersecurity represents a significant growth opportunity in the technology sector. The company is currently conducting due diligence on several potential acquisition targets and is optimistic about the quality of its pipeline. Further updates will be provided as discussions progress.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.